RHÖN-KLINIKUM Aktiengesellschaft (ADR)

General ticker "RKAGY" information:

  • Sector: Health Care
  • Industry: Medical - Care Facilities
  • Capitalization: $1.1B (TTM average)

RHÖN-KLINIKUM Aktiengesellschaft (ADR) follows the US Stock Market performance with the rate: 32.0%.

Estimated limits based on current volatility of 0.0%: low 8.16$, high 8.16$

Factors to consider:

  • Company pays dividends (annually): last record date 2026-05-29, amount 0.12$ (Y1.47%)
  • Earnings for 3 months up through Q1 exceed our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2025-12-31 to 2027-12-31

  • 2025-12-31 to 2026-12-31 estimated range: [6.86$, 10.20$]
  • 2026-12-31 to 2027-12-31 estimated range: [7.56$, 11.12$]

Financial Metrics affecting the RKAGY estimates:

  • Positive: with PPE of 14.7 at the end of fiscal year the price was neutral
  • Positive: 6.77 < Operating cash flow per share per price, % of 7.16
  • Positive: -13.52 < Operating profit margin, % of 0.23
  • Positive: 3.66 < Industry operating cash flow per share per price (median), % of 4.90
  • Positive: -4.55 < Industry operating profit margin (median), % of -0.34
  • Positive: Industry inventory ratio change (median), % of 0 <= 0
  • Positive: -18.95 < Investing cash flow per share per price, % of -14.66
  • Positive: Inventory ratio change, % of -0.43 <= -0.37
  • Negative: 0.33 < Interest expense per share per price, % of 0.33
  • Negative: Industry earnings per price (median), % of 0 <= 0

Similar symbols

Short-term RKAGY quotes

Long-term RKAGY plot with estimates

Financial data

YTD 2023-12-31 2024-12-31 2025-12-31
Operating Revenue €1,463.98MM €1,595.62MM €1,859.32MM
Operating Expenses €1,423.58MM €1,547.47MM €1,855.10MM
Operating Income €40.40MM €48.15MM €4.22MM
Non-Operating Income €7.33MM €8.05MM €38.96MM
Interest Expense €3.70MM €3.40MM €2.89MM
Income(Loss) €47.73MM €56.20MM €43.18MM
Taxes €7.56MM €11.00MM €8.32MM
Net Income(Loss)* €38.71MM €43.35MM €33.11MM
Stockholders Equity €1,252.04MM €1,295.93MM €1,320.06MM
Inventory €34.21MM €37.46MM €40.56MM
Assets €1,770.52MM €1,856.48MM €1,818.40MM
Operating Cash Flow €109.00MM €127.60MM €61.95MM
Capital expenditure €62.80MM €70.40MM €95.19MM
Investing Cash Flow €40.90MM €-50.40MM €-126.89MM
Financing Cash Flow €-21.20MM €-3.30MM €-40.34MM
Earnings Per Share** €0.29 €0.34 €0.25
Ordinary share to ADR 1.00x 1.00x 1.00x

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.